Each month, we compile and present a comprehensive up-to-date list of recently started clinical trials to keep you informed of the latest advancements and research in the medical field. To be the first to know about new clinical trials Register Now for free

The below are the clinical trials posted for the first time in October 2024.

Phase 4:

  1. The Effect of Reduced Bleomycin in Electrochemotherapy Treatment
  2. Dermoscopy vs Standard Marking for the Completeness of Excision of Keratinocyte Skin Cancers: The ClearMark Trial
  3. COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcer
  4. To Explore the Effect of Huaier Granule on the Negative Conversion Rate After the CEA Level Increases Again After Colorectal Cancer Surgery
  5. Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
  6. PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic Malignancies
  7. Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy
  8. The Efficacy and Safety of Different Combination Regimens of Inetetamab in First-line Treatment of HER2 Positive Metastatic Breast Cancer
  9. Bowel Preparation in Colonoscopy: Lactulose Vs Polyethyleneglycol, Randomized Double-blind Comparative Clinical Trial, Multicenter Study.
  10. Investigating the Optimal Remifentanil and Dexmedetomidine Concentration for Uterine Fibroid Ablation
  11. Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients
  12. Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

Phase 3:

  1. Long-term Follow-up of Participants Treated with Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies
  2. BladdEr Full OR Empty for Pelvic Radiation Therapy
  3. A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
  4. Pelvis ART is a Two Phase Study Looking at Using Adaptive Radiotherapy to Help Reduce Toxicity for Cancer Patients Receiving Radiotherapy to the Pelvic Region. Adaptive Radiotherapy is a New Technology That Provides the Ability yo Account for Daily Changes in Anatomy.
  5. A Randomized Controlled Trial of a Web-based Platform for Cancer Pain Management
  6. Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors
  7. Capivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese Patients
  8. Dalpicilib-Enhanced Vs. Standard Endocrine Therapy in ER+ HER2- Early Breast Cancer
  9. Reducing Inflammatory Syndrome in Surgery - Colorectal (RISIS-CR) Trial
  10. A Randomized Secondary Adjuvant Treatment Intervention Study Comparing Trastuzumab-Deruxtecan to SOC Therapy in EBC Patients with Molecular Relapse
  11. Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
  12. Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer
  13. Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
  14. D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer
  15. Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment
  16. A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
  17. Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer
  18. SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC
  19. Similar Efficacy, Safety, and Immunogenicity of FYB206 in Comparison to Keytruda as add-on to Chemotherapy in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC)
  20. A Study of Olverembatinib in SDH-deficient GIST.
  21. Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse
  22. A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
  23. REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial
  24. Segmentectomy for Solid-dominant Lung Cancer
  25. Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
  26. A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC
  27. Phase 3 Study of RMC-6236 in Patients with Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
  28. Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
  29. Clinical Study of the Efficacy and Safety of BCD-263 and OpdivoΒ® As Monotherapy in Subjects with Advanced Melanoma of the Skin
  30. Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)
  31. Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer
  32. Evaluation of Sonelokimab in Patients with Active Psoriatic Arthritis and Anti-TNFΞ± Inadequate Response
  33. A Study of Pembrolizumab (MK-3475) With or Without V940 in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
  34. SHR-A1904 Compared With Investigator's Choice of Therapy in Claudin18.2 Positive Patitens With Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
  35. Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
  36. Neoadjuvant Toripalimab + Chemotherapy Β± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT)
  37. A Study of Simmitinib Versus Chemotherapy for Participants With Advanced Oesophageal Squamous Cell Carcinoma
  38. A Study of Ifinatamab Deruxtecan in Subjects With Advanced or Metastatic ESCC (IDeate-Esophageal01)
  39. A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma
  40. TPC Combined With Cadonilimab VS. TPC Alone in Anti-PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma
  41. Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma
  42. Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery
  43. IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2)
  44. A Study of Different Programs to Help ALL Patients With Taking Maintenance Medicine at Home
  45. Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).

Phase 2-3:

  1. A Trial of LNS8801 with or Without Pembrolizumab in Patients with Refractory Melanoma
  2. Anlotinib Plus Nab-Paclitaxels and S-1 for Patients with Advanced Biliary Tract Cancer As Second-Line Treatment
  3. Single-arm Clinical Trial of TACE in Combination With Acoradine as Adjuvant Therapy After Surgery in Patients With Hepatocellular Carcinoma at High Risk of Recurrence
  4. Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache

Phase 2:

  1. A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine
  2. Modified Capecitabine and Oxaliplatin (mCAPOX) for Patients with GI Malignancies
  3. A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy
  4. Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors
  5. Phase II Study to ONO-4538 in Patients With Rhabdoid Tumor
  6. PUL-042 Treatment in Patients with Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
  7. An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors
  8. A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China
  9. Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer
  10. Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia
  11. Efficacy of Pemigatinib in Patients With Solid Tumors Characterized by an Alteration of the Gene FGFR in Tumor Cells
  12. Fruquintinib in Combination With Tislelizumab Followed by Radiotherapy in Esophageal Squamous Cell Carcinoma
  13. A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
  14. RATT Vs. VATT for Early-stage TETs
  15. A Multicenter Study on the Treatment of MDS/MPN Overlap Syndrome With AZA or Rux Combined With Selinexor
  16. Tranilast vs. Steroids to Prevent Esophageal Stricture (TAPES) After Endoscopic Resection for Superficial Neoplasms
  17. Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC
  18. A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01)
  19. Agnostic Therapy in Rare Solid Tumors
  20. Suprachoroidal Administration in Subjects With Choroidal Metastasis From Breast or Lung Primary Tumors
  21. Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma
  22. CGA Guided Ultrafractionated RT and Systemic Treatment in Elderly or Frail Patients with Inoperable Localized CRC
  23. CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC
  24. A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients with Advanced High-Grade Osteosarcoma
  25. Genomic and Transcriptomic Predictors of Sequential SG Sensitivity After T-DXd in ER+/HER2-Low Metastatic Breast Cancer
  26. Clinical Study of Radiotherapy Combined With Camrelizumab and Apatinib in the Treatment of Liver Cancer Patients .
  27. Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment
  28. Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors
  29. Efficacy and Safety Study of Disitamab Vedotin + RC148 vs. Albumin-Paclitaxone Β± Toripalimab in HR-/HER2-low Breast Cancer
  30. Neoadjuvant Pembrolizumab with a Watch-and-wait Strategy for Patients with DMMR/MSI-H Localized Colon Cancer: GERCOR G-109 PRODIGE 84 PREMICES Phase II Trial
  31. Study of Senaparib in Combination With Temozolomide
  32. A Trial of Camrelizumab Plus Nab-paclitaxel and Levocetirizine in Metastatic or Recurrent TNBC
  33. Multigene Risk Score Combined With Ki-67 Dynamic Assessment in Stratified Neoadjuvant Endocrine Therapy Treatment With or Without CDK4/6 Inhibitors in HR+/HER2- Breast Cancer
  34. Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)
  35. Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
  36. Neoadjuvant Toripalimab Plus Liposomal Paclitaxel and Carboplatin in Patients With Localized TNBC (NeoTOP)
  37. A Study of HRS-4642 Monotherapy or in Combination with Adebrelimab in the Treatment of Advanced Biliary Tract Tumors.
  38. Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study
  39. FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
  40. Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)
  41. Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer
  42. Isunakinra Alone and in Combination with Pembrolizumab in Patients with Colorectal Cancer (MSS)
  43. A Single-arm, Open-label, Prospective Clinical Study of Surufatinib Combined With Immunotherapy and Chemotherapy for Unresectable or Metastatic Biliary Tract Cancer.
  44. Combination of TURP and Standard Systemic Therapy for MPCa
  45. Neoadjuvant Chemotherapy + PD-1 Inhibitor+Different Radiotherapy Fractionations for HR+/HER2- Breast Cancer
  46. A Phase 2 Clinical Study of ABSK061 and ABSK043
  47. Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse
  48. NEoadjuvant Olaparib Combination OvArian Cancer Targeted Study
  49. Nal-IRI/5-FU/LV Chemotherapy Combined with PD-L1 Inhibitor and Multi-target Anti-angiogenic Small MoleculeΒ±SBRT As Second-line Therapy in Metastatic Pancreatic Cancer Patients
  50. Efficacy Analysis of Neoadjuvant Treatment in Lung Cancer Using Low-dose Nivolumab Combined With Chemotherapy
  51. Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.
  52. Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes
  53. Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer
  54. ARX788 in HER2-positive Metastatic Breast Cancer Patients
  55. A Study of ES102 in Combination With Toripalimab in Subjects With Advanced Non-small Cell Lung Cancer
  56. Sasanlimab As Maintenance Treatment Based on Clinical Response to Neoadjuvant Treatment in Molecularly Categorized Muscle Invasive Bladder Cancer Patients
  57. Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer
  58. A Study to See How Well and How Safely Different Treatments Work in a Group of Participants With Non-Small Cell Lung Cancer (NSCLC)
  59. Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical Trial
  60. Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC
  61. Open Label Study to Evaluate the Safety and Efficacy of NDV01 KIT in High Grade NMIBC
  62. EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active
  63. All Trans Retinoic Acid Combined with Toripalimab+Chemotherapy for Locally Advanced Inoperable or Metastatic Triple Negative Breast Cancer：a Multi-center, Multi-cohort Phase II Trial
  64. Third-generation EGFR-TKI Plus Anlotinib as Maintenance for NSCLC With Small Cell Transformation After EGFR-TKI Resistance
  65. Local Injection and Systemic Therapy in the Treatment of NSCLC.
  66. Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC)
  67. Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
  68. High-dose Furmonertinib or Combined with Chemotherapy in EGFR-mutant Advanced NSCLC After Disease Progression on Third-generation EGFR-TKI
  69. Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
  70. First Line Therapy for Extensive SCLC Patients, Treated with Chemo+Keytruda Followed by Keytuda+Trodelvy
  71. Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.
  72. Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
  73. Efficacy and Safety of a Two-week Dosing Regimen of Vinorelbine Combined with Liposomal Doxorubicin in the Treatment of HER2-negative Advanced Breast Cancer
  74. Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT
  75. Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC).
  76. TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal Hypertension
  77. Vebreltinib for Neoadjuvant in MET-altered Stage IIIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)
  78. Folate Receptor Alpha Dendritic Cells (FRΞ±DCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial
  79. A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib
  80. Ex Vivo Drug Response Evaluation for Next Generation Care of Brain Metastases
  81. A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced, Recurrent Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer
  82. Clinical Trial Evaluating Secondary HPV Vaccination After Treatment of High-grade Cervical Lesions (HPV2-2303)
  83. NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma
  84. LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma
  85. SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer
  86. Pneumonitis Prevention Protocol Using Pentoxifylline and Ξ‘-tocopherol in Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation
  87. Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis
  88. Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma
  89. Molecular Subtype Combined with Early Minimal Residual Disease to Optimize the Treatment of Newly Diagnosed Acute Myeloid Leukemia
  90. Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer
  91. Clinical Study of Neoadjuvant Targeted Therapy for Ameloblastoma
  92. A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung Cancer
  93. Preoperative Partial Breast Reirradiation and Repeat Breast-conserving Surgery in Patients with Recurrent Breast Cancer: the REPEAT Trial
  94. Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body
  95. CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric Cancer
  96. Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy
  97. G-CSF After Chemo-radiation in Patients with Glioblastoma
  98. Lovastatin and Pembrolizumab for the Treatment of Patients with Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
  99. A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
  100. Study Evaluating the Efficacy and the Tolerance of Immunochemotherapy and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients with Stage III Lung Cancer
  101. Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib
  102. Evaluating RhPDGF-BB-Enhanced Wound Matrix for Head and Neck Reconstruction
  103. A Clinical Trial Evaluating the Efficacy and Safety of Disitamab Vedotin Plus Tislelizumab Combined with Re-TURBT in the Treatment of HER-2-high Expression(2+-3+) Non-muscle Invasive Bladder Cancer At High-risk and Very High-risk.
  104. A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
  105. A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
  106. Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)
  107. Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC
  108. Study of TPEx Followed by a Maintenance With Avelumab and Cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma of the H&N
  109. Locally Advanced NSCLC Treated With Radiochemotherapy: Phase 2 Study on the Value of a Stereotactic Boost
  110. Window of Opportunity Study of Topical Tranexamic Acid for Cutaneous Squamous Cell Carcinoma
  111. Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in Sexual and Gender minoriTies
  112. Neoadjuvant Opdualag Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma
  113. EPIC- Extracorporeal Photopheresis (ECP) for Immune-related Colitis
  114. Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC
  115. Hepatic Arterial Infusion Chemotherapy With Lipiodol Embolization in Advanced Hepatocellular Carcinoma
  116. Endoscopic Retrograde Cholangiopancreatography With Radiofrequency Ablation (ERCP-RFA) Combined With Envafolimab and Surufatinib Sequential Therapy for Unresectable Biliary Tract Carcinoma
  117. IN10018 with Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 Trial
  118. Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma
  119. Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic Cholangiocarcinoma
  120. Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF Β± Lenvatinib As First-line Treatment for Advanced ICC
  121. Venetoclax + Azacitidine in Patients with Acute Myeloid Leukemia
  122. Efficacy of Gilteritinib in Combination With FLAI as Induction Therapy of FLT3-positive Acute Myeloid Leukemia
  123. BCL2i CLAG-M in R/R Acute Myeloid Leukemia
  124. Efficacy of Venetoclax Combined with Intensive Chemotherapy in Different Subgroups of AML
  125. An Open-Label Clinical Study of the Efficacy and Safety of BCD-248 in Patients with Relapsed/Refractory Multiple Myeloma
  126. Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease
  127. The Clinical Study of the Treatment of Patients With Type I Neurofibromatosis With Smetinib Hydrosulfate Capsule
  128. Clinical Study on the Treatment of Type I Neurofibromatosis With Smeitinib Hydrosulfate Capsule
  129. A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis
  130. An Investigator-Initiated, Phase II, Multicenter, Open-Label, Single-Arm, Prospective Clinical Trial to Evaluate the Efficacy and Safety of Alternating Bortezomib-Based Regimens in Combination With DaratUMumab Followed by Maintenance With Daratumumab in the Frontline Setting of Primary Plasma CEll L
  131. High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)
  132. G-Pola-ZLP in Diffuse Large B-Cell Lymphoma
  133. Pola-ZR2P in Previously Untreated DLBCL
  134. A Prospective, Single-Center Study Evaluating the Efficacy and Safety of Glofitamab Combined With Orelabrutinib and Bortezomib in Patients With High-Risk Mantle Cell Lymphoma
  135. Selinexor Combined With BEAM for ASCT in R/R DLBCL With MYC Positive
  136. Large Fraction Radiation Therapy Combined With Lenalidomide, and Glofitamab in Refractory Relapsed DLBCL
  137. A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of Newly Diagnosed Peripheral T Cell Lymphoma Patients (GOLDEN Study) and Correlative Study
  138. Olverembatinib as Maintenance Therapy or Preemptive Therapy After Allo-HSCT in Ph+ALL
  139. ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT
  140. Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
  141. Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia
  142. Zanubrutinib Plus Rituximab As Front-line Treatment for Mucosa-associated Lymphoid Tissue Lymphoma (MALT)
  143. Orelabrutinib in Combination with R-CHOP for CD5-positive DLBCL Patients（Rocket Trial）
  144. Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations
  145. A Study to Investigate Sonrotoclax Combined With Zanubrutinib Versus Zanubrutinib Alone in Participants With Previously Untreated Chronic Lymphocytic Leukemia

Phase 1-2:

  1. Study of LM-299 in Subjects Advanced Malignant Tumors
  2. A Phase II Open-label Study of Olutasidenib Post-transplant Maintenance Therapy for Patients with IDH1-mutated Myeloid Malignancies
  3. HX044,FIH Study in Patients With Advanced Solid Tumor Malignancies
  4. A Clinical Study of SHR-3276 for Injection in Patients With Advanced Malignant Tumors
  5. Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Anti-PD-1/PD-L1 Therapy in Patients With Solid Tumors
  6. Study of JK06 in Patients With Unresectable Locally Advanced or Metastatic Cancer
  7. A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors
  8. An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours.
  9. A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)
  10. A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
  11. 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
  12. Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors
  13. First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid Tumors
  14. Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study
  15. A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants with Advanced Solid Tumors
  16. BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial Cancer
  17. First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
  18. Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma
  19. Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
  20. Elimination of Prostate Cancer Treatment Side Effects Using a Nutraceutical
  21. A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
  22. Trial of THEO-260 in Ovarian Cancer Patients
  23. BURN Study: Buffered Lidocaine in Reducing Pain from Prostate Biopsy
  24. A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
  25. TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
  26. YL-13027 and/or HY-0102 Combined With AG Regimen Chemotherapy for Metastatic Pancreatic Cancer
  27. Dose Finding, Efficacy and Immunological Response of IP-001 Following RFA, MWA or IRE for CRLM
  28. Safety of HRX215 in Patients After Minor and Major Liver Resection
  29. Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer
  30. Support for Bereaved Cancer Caregivers
  31. A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
  32. RC48 Monotherapy or Combination With Envafolimab for CDK12 Alterations mCRPC With Standard Treatment Failure
  33. A Study of RNK08954 in Subjects With Advanced Solid Tumors With KRAS ((Kirsten Rat Sarcoma) G12D Mutation
  34. 3-Dimensional Virtual Reality Modelling With Intravascular Indocyanine Green Fluorescence Mapping for Targeted Pulmonary Segmental Resection Trial
  35. Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
  36. Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors
  37. PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma
  38. A Study to Assess the Efficacy and Safety of WSD0922-FU in Patients with EGFRm+ Advanced Non-small Cell Lung Cancer
  39. Tebentafusp-tebn With LDT in Metastatic UM
  40. AK112 and Cadonilimab Combined With Chemotherapy for 1L Treatment of Metastatic Pancreatic Cancer
  41. Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)
  42. BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma
  43. Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK
  44. New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study
  45. A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma
  46. CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma
  47. Low-grade UTUC Treated with Nadofaragene Firadenovec Administered to Renal Pelvis
  48. Ablative Radioembolization of Renal Cell Carcinoma Trial
  49. Effect of Subcutaneous Polyvidone Collagen Treatment on Hand Recovery in Adult Rheumatoid Arthritis.
  50. Mezigdomide and Elranatamab for Relapsed And/or Refractory Multiple Myeloma
  51. A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
  52. A Study of AK129 With or Without AK117 in PD(L)1-refractory Classic Hodgkin Lymphoma
  53. Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALL
  54. Cell Therapy with Anti-CD19 CAR-NK Cells in Patients with Relapsed or Resistant B-ALL
  55. Afatinib in Patients with Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

Phase 1:

  1. A Multicenter, Open Label Phase I Clinical Trial Evaluating the Safety and Pharmacokinetics of TQB2252 Injection in Subjects With Advanced Malignant Tumors
  2. Clinical Evaluation of [177Lu]Lu-BQ7876 for Targeting of Prostate-Specific Membrane Antigen
  3. A Study to Investigate the Safety and Efficacy of KQB198 As Monotherapy and in Combination in Participants with Advanced Hematologic Malignancies
  4. A Study of CHS-114 in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
  5. First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
  6. A Study of SHR-3821 Injection in Subjects With Advanced Solid Tumors
  7. Study of BM230 in Patients With Advanced Solid Tumors
  8. Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients with Resectable Brain Tumors
  9. A Second Psilocybin Group Therapy for the Treatment of Cancer-Related Anxiety in Partial Responders With Metastatic Cancer
  10. Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors
  11. Clinical Study of CVL006 Injection in Advanced Solid Tumors
  12. A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients with Advanced Solid Tumors and Hepatocellular Carcinoma (HCC)
  13. 5G-EMERALD: Amivantamab in Malignant Brain Tumours
  14. A First-in-Human Study of BG-C137, an Anti-FGFR2b Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
  15. Anti-GD2 ADC M3554 in Advanced Solid Tumors
  16. A Clinical Study of Paclitaxel Cationic Liposomes for the Treatment of Patients With Advanced Solid Tumors
  17. A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
  18. A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
  19. Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
  20. A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid Tumors
  21. A Study of Ziftomenib, an Oral Menin Inhibitor, in Combination with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumors (GIST)
  22. A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers With Specific Genetic Changes Called KRASG12C Mutation
  23. Clinical Trial of TQB3002 in Patients With Advanced Cancers
  24. A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
  25. Phase Ib Trial of HS-20117 in Combination with Other Drugs in Advanced Solid Tumors
  26. First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients with Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers
  27. Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors
  28. MRI-Guided Ultrasound Stimulated Microbubbles Radiation Treatment for Patients with Chest-Wall and Locally Advanced Breast Cancer
  29. A Clinical Trial to Evaluate the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects
  30. A Study of NILK-2301 in Patients with Locally Advanced or Metastatic Low Tumor Volume (LTV) Colorectal Cancer
  31. Dose Escalation and Expansion of BBO-10203 in Advanced Solid Tumors (BREAKER-101)
  32. Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors
  33. A Phase 1, Randomized, Crossover Study to Evaluate the Relative Bioavailability and Food Effect of HRS-8080 in Healthy Subjects
  34. Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients With Advanced Solid Tumors
  35. A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
  36. Chronic CED of TPT for Recurrent Malignant Glioma
  37. Pulse Radiotherapy to Overcome Metastatic Immune System Evasion in Lung Cancer
  38. Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer
  39. A Study of JNJ-89402638 for Metastatic Colorectal Cancer
  40. A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
  41. STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma
  42. Atovaquone Combined with Radiation in Children with Malignant Brain Tumors
  43. GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy
  44. MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma
  45. A Clinical Trial Aimed At Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer
  46. Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLC
  47. A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL)
  48. CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors
  49. Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma.
  50. Clinical Study of Therapeutic Immunological Agent for EBV Lymphoproliferative Diseases
  51. A Study to Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23 Alone or in Combination with L19-IL2 As a Treatment of Metastatic FAP-positive Solid Tumors
  52. Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
  53. A Phase I Study of CFT8919 in Patients With Advanced NSCLC
  54. Perioperative Fostamatinib with Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer
  55. Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel)
  56. Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined with CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients with Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)
  57. A Phase I Clinical Study of Intratumoral Injection GC001 in Patient With Recurrent or Progressive Gliomas
  58. Phase 1 Open-label Study of 123I-ATT001 in Subjects with Relapsed Glioblastoma
  59. Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinomas
  60. 68Ga-NYM096/177Lu-NYM096 in Metastatic CcRCC
  61. ICP-248 in Combination with Azacitidine in Treatment-NaΓ―ve Subjects with Acute Myelogenous Leukemia(AML) or Previously Treated Relapsed/Refractory Subjects with Acute Myelogenous Leukemia(R/R AML).
  62. Dose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagnosed AML Patients
  63. APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
  64. 2321GCCC: CRD3874-SI in Patients with Relapsed/refractory AML
  65. A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
  66. SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
  67. A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined with Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation.
  68. Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma
  69. Safety of Anal Curcumin
  70. A Study of ONO-7018 in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
  71. Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas
  72. Study to Investigate Intravenous Blinatumomab in Japanese Adult Participants With Newly Diagnosed Philadelphia-negative B-precursor Acute Lymphoblastic Leukemia (B-ALL)
  73. Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL
  74. A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
  75. An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
  76. Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapyβ„Ά in Patients With Sleep Deprivation and Chronic Insomnia
  77. The Effectiveness of Astaxanthin Supplementation on the Clinical Symptoms and Cardio-metabolic Profile in Women with Polycystic Ovary Syndrome

Early Phase 1:

  1. Diagnosis of Metastatic Tumors on 68Ga-FAPI-RGD PET-CT and Radioligand Therapy With 177Lu-FAPI-RGD
  2. Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors
  3. 177Lu-TATE-RGD in Patients With SSTR2 and Integrin Ξ±VΞ²3 Positive Tumors
  4. TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor
  5. 177Lu-JH04 in Patients with FAP-Positive Tumors
  6. 64Cu-LLP2A for Imaging Hematologic Malignancies
  7. BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies
  8. Effect of Propofol and Sevoflurane Anesthesia on HSP70 Expression in Tumor Cells
  9. [177Lu]Lu-AKIR001 First-in-human Study
  10. Universal CAR-T Cells (REVO-UWD-01) for Metastatic Colorectal Cancer
  11. Exploratory Study on the Safety and Efficacy of Disitamab Vedotin in Combination with Anlotinib Hydrochloride for the Treatment of HER-2-expressing Recurrent Platinum-resistant Ovarian Cancer.
  12. PET-imaging of Two Vartumabs in Patients with Solid Tumors
  13. An English/Spanish Mobile Augmented Reality Pain Assessment App for Hispanic/Latino Pediatric Cancer Patients
  14. A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4Ξ± SrRNA in Treating Metastatic CRC Patients
  15. A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors
  16. Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer
  17. A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision
  18. Universal CAR-T Cells (REVO-UWD-03) for Advanced Hepatocellular Carcinoma and Lung Cancer
  19. Phase IIT Trial of SNA014
  20. Effects of Intranasal Ketamine on Depression and Anxiety in Palliative Care Cancer Patients
  21. Window of Opportunity Study of DSP-0390 in Gliomas
  22. Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma
  23. Study on the Safety and Efficacy of BST06 Injection in the Treatment of Advanced Hepatocellular Carcinoma
  24. Neoadjuvant Intralesional Injection of Talimogene Laherparepvec
  25. EX02 CAR-T Cells for Relapsed and Refractory Acute Myeloid Leukemia
  26. Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma
  27. Safety and Efficacy of PRG-2302 for Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia Disease.
  28. Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
  29. Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL
  30. Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma
  31. Effects of a Strength Physical Exercise Program in Chronic Lymphocytic Leukemia Patients

Phase Not Applicable:

  1. Effectiveness of Central Oncology Navigation and the Use of an ORN
  2. Effect of Nurse Navigation Program on Cervical Cancer Screening Behaviour of the Women Aged 30-65
  3. ESense-Cancer: Adapting an Online Intervention for Sexual Health Concerns to Gynecologic Cancer
  4. Effect of the Benson Relaxation Technique on Clinical Outcomes of Oncology Patients Admitted to Intensive Care Units
  5. Prospective Evaluation of Frailty in Patients with Head and Neck Tumors Before Curative Intended Therapy
  6. Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer Care
  7. IMRT Versus IMPT With Concurrent Chemotherapy for Locally Advanced Anal Canal Cancer
  8. A Pilot and Mixed-Methods Study of GYNecologic Cancer-Related COGnitive Impairment
  9. AI-Assisted Non-Contrast CT for Multi-Cancer Screening
  10. Biomarker Platform (Virtual Nodule Clinic) for the Management of Indeterminate Pulmonary Nodules
  11. Food Safety Educational Training Program to Improve Food Safety Knowledge and Behaviors in Cancer Patients Receiving Treatment
  12. Mitoxantrone Hydrochloride Liposome, Standard-dose of Cytarabine and Venetoclax in the Treatment of R/R AML
  13. KNUCH CadAI-B-1(KCB-1)
  14. Functional, Personalised and Integrated Profiling of Biopsied Pancreatic Tumours (CancerProfile by FNB)
  15. Mobile Outreach Screening of High-Risk Human Papillomavirus Infection in Women with Limited Access to Health Services in Seine-Saint-Denis (greater Paris Area, France)
  16. Group Meaning-Centered Psychotherapy for the Improvement of Wellbeing in Caregivers of Patients with Advanced Cancer
  17. Spatially Fractionated Radiation Treatment for Gynaecological Cancers
  18. Anti-HER2 CAR-T Cell Injection in Patients With HER2-positive Advanced Malignant Solid Tumors
  19. A Multi-cohort Study of Efbemalenograstim Alfa Injection for Preventing ANC Reduction in Solid Tumor Patients Post Immune-chemotherapy.
  20. Image-guided Ultrasound Robotic Intraoperative Evaluation of Lymph-nodes Status in Gynecological Malignancies
  21. Implementing Surgery School Prehabilitation Using Telehealth
  22. Enhancing Quality of Life in Cancer Patients Through Tailored Nutrition Support: a Comprehensive Approach
  23. Assessment of Oncological Safety, Quality of Life, and Environmental Impact of the Green Breast Surgery Protocol
  24. Supporting Spiritual Wellbeing in Young Adults With Cancer Using a Digital Health Approach: A Feasibility Study
  25. A Clinical Trial of the Administration of Light Therapy to Prevent and Treat Mouth Sores in Children With Cancer
  26. Group Advanced Care Planning Pilot for Veterans
  27. Lung Cancer and Aging: Improving Well-being for Older Adults With Lung Cancer
  28. The Diagnostic Value of FAPI PET/CT in Staging of Newly Diagnosed Prostate Cancer
  29. Partial Prostatectomy for Prostate Cancer
  30. Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy of Immunotherapies
  31. Large Segmentation Radiotherapy Β± Deep Inspiration Breath Hold(DIBH) for Left Breast Cancer
  32. Nurse-led Primary Healthcare Intervention Model in Women's Health Management in Hong Kong
  33. Research of the Application of Pancreatic Cancer Screening Artificial Intelligence Model "PANDA PLUS"
  34. Community Support Program for Lung Cancer Screening Volume II
  35. EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial)
  36. Optical Surface Guidance for External Radiotherapy of Head and Neck Cancer
  37. Efficacy of RUS GA Surgical Navigation for Robot-assisted Distal Gastrectomy in Gastric Cancer Patients
  38. Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer
  39. Behaviour Change for Cancer Survivors Trial
  40. TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT
  41. Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors
  42. The PharmFIT Study
  43. Evaluation of the Bexa Breast Examination
  44. Effects of Yoga on Children With Cancer
  45. Exercise and Nutrition for Older Cancer Survivors and Their Support Person: the Vitality Study
  46. Effectiveness of an N-acetylcysteine and Urea-based Cream in Prevention of Capecitabine-induced HAND-foot Syndrome in Breast Cancer Patients
  47. A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients
  48. Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy
  49. SCINTIX [BgRT} Using RMRS in Solid and Soft Tissue Tumors
  50. Cola Ingestion for Esophageal Bolus Impaction
  51. Comparison of Whole Body DWI to FDG PET
  52. Chemoimmunotherapy Followed by Surgery for Oligometastatic Esophagogastric Cancer: (TORO Protocol)
  53. Mid-transverse Process Combined With Erector Spinae Block Versus Paravertebral Plane Block
  54. Virtual Ileostomy Versus Diverting Ileostomy in Patients Undergoing Total Mesorectal Excision
  55. Ultrahypofractionated Whole Breast Radiation Following Chemotherapy
  56. Supplemental Screening for Women With Extremely Dense Breast Tissue: the DENSE-2 Trial
  57. Partial Pressure of Oxygen Control Method in Identification of Intersegmental Plane
  58. [18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary Origin
  59. Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions
  60. Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life
  61. Pain Caregiver Resource (PainCaRe)
  62. Evaluation of a Novel Technique for the Discovery of New, Tumor-specific Targets for the Deployment of Innovative Immunotherapeutics Against Cancer.
  63. WATER IV Prostate Cancer
  64. Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing 2 (ESPRIT-AI-2)
  65. Patient Care Outreach, Navigation, Technology and Support 2.0
  66. Developing and Testing the Effect of Online Interactive Videos in Improving Low Anterior Resection Syndrome.
  67. The Mid-point Transverse Process to Pleura Block Versus Serratus Anterior Plane Block for Postoperative Analgesia After Modified Radical Mastectomy
  68. Retrolaminar Block Versus Subcostal Transversus Abdominis Plane Block in Liver Resection Surgery
  69. Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins
  70. Pilot Study of Neoadjuvant Chemotherapy Combined With Immunotherapy and Multimodal Thermal Therapy for HER2-negative Breast Cancer
  71. Exercise Program on Pain, Physical Function, and Quality of Life in Breast Cancer Survivors
  72. Artificial Intelligence Models for Precision Prediction and Treatment of Prostate Cancer
  73. Assessing and Addressing Follow-up Care Needs That Will Facilitate Care Transitions for Cancer Survivors
  74. Oxford Pleural Embolisation Trial
  75. Community Co-produced Action for Improved Access to Cervical Cancer Screening in Cameroon
  76. The Safety and Efficacy of Multimodal Thermal Therapy in the Treatment of Early-stage Invasive Breast Cancer
  77. Dietary Restriction to Prevent Cardiotoxicity in Breast Cancer Patients
  78. The AIDPRO-CRC Trial
  79. Swebcg 91:A RT. Breast Conserving Surgery With or Without Radiotherapy for Breast Cancer Patients
  80. Left Lateral Position Versus Supine Position in Colonoscopy
  81. Alternative Physical Activity Strategies for Breast and Prostate Cancer Survivors
  82. A Chatbot to Reduce Physical and Psychological Distress of Patients With Head and Neck Cancer Undergoing Radiotherapy
  83. Effect of Intrathecal Morphine on Quality of Recovery After Laparoscopic Colorectal Cancer Surgery
  84. Feasibility of Intermittent Fasting During Chemotherapy
  85. Improving Detection of Early Lung Cancer in a Diverse Population (IDEAL) Study
  86. Planning Grant for TOPS for African American Breast Cancer Survivors
  87. A Clinical Trial Comparing Staged Turnbull-Cutait Pull-through Anastomosis With Direct Anastomosis Plus Prophylactic Ileostomy in the Treatment of Low Rectal Cancer After Internal Sphincter Resection
  88. DHF-20-1839-2: Clinical Performance Study Protocol for TherascreenΒ® KRAS RGQ PCR Kit
  89. Intervening on Women's Health for Rural Young Cancer Survivors
  90. Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques
  91. Focal Cryoballoon Ablation for Malignant Dysphagia
  92. Messaging Intervention to Increase Medicare Annual Wellness Visits -- the NUDGE AWV Clinical Trial
  93. A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer
  94. SEgmentectomy Versus Lobectomy in T1C Non-Small Cell Lung Cancer (SELTIC)
  95. Head and Neck Cancer Rehabilitation: the CaRe Feasibility Study
  96. Contrast Enhancement Mammography vs MRI for the Surveillance of Women at High Risk of Breast Cancer: Con-trust Randomized Controlled Trial
  97. Application of PET/MRI in the Evaluation of the Efficacy of Neoadjuvant Therapy for Locally Advanced Rectal Cancer
  98. A Study on the Safety and Efficacy of BST08 in Treating Advanced Non-Small Cell Lung Cancer
  99. Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care
  100. Evaluating High-dose Furmonertinib With Bevacizumab and Pemetrexed for EGFRm NSCLC With Leptomeningeal Metastasis
  101. Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care
  102. Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1
  103. Neck Observation or Elective Neck Dissection in CT1N0M0 OSCC
  104. Reminder App to Optimize Bladder Filling During Radiotherapy for Prostate Cancer
  105. Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTC
  106. MIRRORS-FROZEN - Comparing Open Vs Robotic Surgery in the Management of Women with Complex Pelvic Adnexal Masses ≤ 8cm.
  107. Association of Cancer-Associated Fibroblast Density in the Peritumoral Stroma with Clinicopathological Data in Breast Cancer
  108. Integrative Approaches for Cancer Survivorship (IACS3)
  109. Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer
  110. Laughter Yoga Effect on Cancer Patients' Physiopsychological Symptoms
  111. Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer
  112. Selective Lymph Node Resection for Invasive Non-small Cell Lung Cancer with the CTR of 0.5-1 and the Diameter of ≤ 2 Cm
  113. Skeletal Muscle Mass Changes on Images for Prediction of Prognosis After Exercise Training in HNSCC Patients
  114. Mindfulness Intervention for Improving Nutrition in the Digital Kitchen Among Stage I-III Breast Cancer Survivors, MIND Trial
  115. Decision Support Intervention of Minor Cancer Patients and Their Parents
  116. Effect of Vitamin D Supplementation on Chemotherapy Side Effects After Adjuvant Chemotherapy for Breast Cancer
  117. Understanding the Implementation of Cued Exercise Using Wearable Devices and a Custom Smartphone Application Following Bone Marrow Transplant.
  118. Integrating Telehealth to Advance Lung Cancer Screening
  119. Intervention Development and Evaluation to Reduce Disparities in Quality of Life for Latino Families Impacted by Cancer
  120. Development of an Artificial Intelligence Model for the Identification and Prevention of Smoking-related Diseases.
  121. AI-based Skeleton Recognition System for Rehabilitation Exercise in Breast Cancer Survivors: A Randomized Controlled Trial
  122. Early Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular Carcinoma
  123. Radiotherapy Combined with Systemic Therapy Versus Systemic Therapy for Oligometastatic UTUCs
  124. Efficacy of Psychological Intervention for Children With Cancer
  125. Sentinel Node and Organ-sparing Surgery in Stage I Colon Carcinoma
  126. Sexual and Urinary Function Improvement for Cancer Survivors
  127. OSCAR II STUDY - The ONCObind CTC Removal Study
  128. Cognitive Impairment in Treated Breast Cancer Survivors: Possible Approaches
  129. Utilizing Long-read Sequencing to Investigate the EGFR Landscape of EGFR Positive Lung Cancer Patients
  130. The Effect of Natural Molecules on HPV Infection
  131. DermaSensor Postmarket Surveillance Study
  132. Radical Surgery for Advanced Gastric- or GEJ-cancer With Oligometastatic Dissmination to the Liver
  133. Helping Ovarian Cancer Patients Cope With Their Illness (HOPE)
  134. A Low-Insulinemic Dietary Intervention to Reduce Breast Cancer Risk in High-Risk Women
  135. Evaluation of a Personalised Survivorship Care Plan App for Patients with Melanoma
  136. Effect of Vitamin D Supplementation on the Efficacy and Adverse Effects of Neoadjuvant Therapy in Patients With Breast Cancer
  137. Effectiveness of Self-Physiotherapy in the Management of Lymphedema
  138. Jacobson's Progressive Muscle Relaxation Technique on Children With Leukemia Undergoing Chemotherapy.
  139. Educational Program's Impact on Nurses' Skills in Port-A-Catheter Care for Chemotherapy Patients
  140. Understanding the Preferences and Views of Older Adults on the Use of Geriatric and Objective Functional Assessments for Cancer Treatment Planning.
  141. ECM and Monitoring w/ Alio Smart Patch in Cancer Pts Receiving Chemotherapy
  142. Artificial Intelligence-based Voice Assessment of Children and Adults Respiratory Conditions
  143. Nutritional Language Model
  144. The Ohio State University (OSU) SCREEN Community Program
  145. Fitness and Nutrition in Glioma
  146. Repeatability of Magnetic Resonance Imaging in Patients With IDH1 Mutant Glioma on Ivosidenib
  147. Early Rehabilitation Using Head Impulse Test for Acute Vestibular Deficit
  148. The Radium-select Study
  149. Thermotherapy in Addition to SOC Palliative Radiotherapy
  150. Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients with Head and Neck Squamous Cell Cancer Receiving Cisplatin And/or Radiation
  151. Clinical Research on the Treatment Model of Laparoscopic Colorectal Day Surgery
  152. Two Doses of Dexmedetomidine as Adjuvent to Bupivacaine in Tap Block
  153. Efficacy of Vitamin B1 in Familial Adenomatous Polyposis Patients.
  154. A Prototype AI Algorithm Versus Liver Imaging Reporting and Data System (LI-RADS) Criteria in Diagnosing HCC on CT
  155. Mindfulness Meditation: Alleviating Symptoms and Inflammation in Nurses
  156. Reduction of Postoperative Radiotherapy in Head and Neck Squamous Cell Carcinoma
  157. Right Versus Left Thoracic Surgical Approaches for Siewert II Gastroesophageal Junction Adenocarcinoma
  158. The Yield of Artificial Intelligence (GI Genius) in Lynch Syndrome - a Randomized Tandem-colonoscopy Trial
  159. The Effect of Levonorgestrel Intrauterine System in Preventing Endometrial Polyps Recurrence
  160. Safety and Efficacy of Using a Novel Full Visual Access Platform System in Transvaginal Hysterectomy
  161. Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)
  162. Prospective Study of EndoAim: ASUS AI Solution for Colorectal Polyp Diagnosis
  163. Venetoclax Combined with Intensive Therapy for Acute Myeloid Leukemia Patients with Lower Early Peripheral Blast Clearance Rate After Standard Induction Therapy
  164. ENVELOP: Wound Care Following Pilonidal Sinus Surgery
  165. Comparing the Efficacy of TU-LESS and VNOTES for Hysterectomy of Enlarged Uterus
  166. Exercise During Chemotherapy Treatment As Adjuvant Program in Patients with Lymphoma: EDONOLA Study.
  167. One Trial to Evaluate the Safety, Tolerability and Efficacy of JCXH-213 in Patients With r/r B-NHL
  168. Childhood B-acute Lymphoblastic Leukaemia and Role of CD9 Gene Regulation in Relapse
  169. Blinatumomab as Maintenance Therapy in Patients With High-risk B-lineage Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation
  170. Sphenopalatine Block Vs Dexmedetomidine Infusion in Trans Nasal Endoscopic Pituitary Surgery
  171. Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
  172. Integrative "Omics" Approaches for Leukemia Target Identification and Matched Therapeutic Intervention
  173. Interventions Against Fatigue in Patients with Myasthenia Gravis
  174. Integration to Improve Adolescent Health and HPV Vaccination in Laos
  175. The Impact of Greater Occipital Nerve and Stellate Ganglion Block Treatments on Sleep in Chronic Headache Management
  176. Ultrasound Guided Block of Stellate Ganglion Versus Greater Occipital Nerve in Resistant Migraine and Correlation to Calcitonin Gene Related Peptide
  177. A Study on Pain After Breast Reconstruction
  178. Effect of Targeted Endodontic Microsurgery on Quality of Life and Healing on Mandibular Molars
  179. Treatment of Women with PCOS of Phenotype D
  180. In Vitro Maturation of Human Eggs
  181. Mindfulness-based Stress Reduction in Obese Women With Polycystic Ovary Syndrome (PICOS)
  182. Effect of Coenzyme Q10 Administration on Polycystic Ovary Syndrome

Note

The above Clinical Trial information has been retrieved from ClinicalTrials.gov